Ascend Gene & Cell Therapies is a gene and cell therapy manufacturing specialist that has recently secured a significant £106 million Series A funding round. The company aims to improve therapies by constantly refining and innovating its approach, with a focus on creating effective gene therapies to a world-class standard. Ascend supports manufacturing and process development projects from design through to clinical and commercial scales, and it prioritizes communication, transparency, and building lasting trust with its partners.

Ascend Gene & Cell Therapies

MedPharma is a pharmaceutical company based in the United Kingdom that provides medication and healthcare products.

MedPharma

Workable provides recruiting software and a hiring platform that allows users to find, hire, onboard, and manage employees.

Metric
Company Name	Ascend Gene & Cell Therapies	MedPharma
Symbol
MSH ID	COM:ASCEND-GCTX	UK:MEDPHARMA
Market	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Biotechnology and Therapeutics	Pharmaceuticals
Country	GB	GB
Stage		Venture Round
Employee Count	107
Website	workable.com	medpharma.uk
LinkedIn	ascend-gene-cell-therapies	medpharm
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		1.50K
Web Traffic Growth		-0.24
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ASCEND-GCTX

Workable

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue